文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Andrea Tomisser
发表
The rationale and study design of two phase II trials examining the effects of BI 685509, a soluble guanylyl cyclase activator, on clinically significant portal hypertension in patients with compensated cirrhosis
J. Ertle, J. Trebicka, A. Berzigotti, 2023, Trials.